Company profile

Vernalis

We develop and apply fragment and structure-based methods to solve problems in drug discovery

Industry
Biotechnology Research
Employees
255
Headquarters
Cambridge, Cambs
Founded
1997
LinkedIn followers
9,442
Office locations
1

Vernalis company summary

Vernalis is a company in the Biotechnology Research industry, headquartered in Cambridge, Cambs, founded in 1997. On LinkedIn the company has around 255 employees and 9,442 followers. Its listed specialties include drug discovery, FBLD, structure-based, oncology, structural biology.

What technology does Vernalis use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Vernalis

We develop and apply fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives and inflammation. Our established group of experienced scientists is based at our fully-equipped research laboratories on Granta Park, Cambridge UK. We integrate fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive medicinal chemistry expertise to enable drug discovery on both established and novel targets. We have the experience and capabilities for progressing projects from target identification through to clinical candidate. We have generated lead compounds on kinases, ATPases, protein-protein interactions and GPCRs, leading to clinical candidates for Chk1, Hsp90, Bcl-2, Mcl-1, FAAH and A2A. We balance an internal portfolio of drug discovery projects with fully integrated research collaborations on targets with pharmaceutical companies and academic partners. Our shared-risk approach ensures a high level of engagement from our scientists and rewards success. Current disclosed collaborations include those with Servier, Daiichi Sankyo, Lundbeck and Asahi Kasei Pharma, and we seek additional partnerships.

Specialties

drug discoveryFBLDstructure-basedoncologystructural biologybiophysicsassay technologymedicinal chemistrymolecular modellingprotein engineeringNMRX-Ray crystallographyDMPKsynthetic organic chemistrycheminformaticsSPRITCdrug developmentCNSCell biology

Where is Vernalis located?

Vernalis lists 1 location.

Cambridge, Cambs CB21 6GB, GBHQ
Granta Park

Compare companies similar to Vernalis

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Vernalis
vernalis.com
Biotechnology Research2551997Cambridge, Cambs
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Vernalis

What does Vernalis do?

We develop and apply fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives and inflammation. Our established group of experienced scientists is based at our fully-equipped research laboratories on Granta Park, Cambridge UK. We integrate fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive medicinal chemistry expertise to enable drug discovery on both established and novel targets. We have the experience and capabilities for progressing projects from target identification through to clinical candidate. We have generated lead compounds on kinases, ATPases, protein-protein interactions and GPCRs, leading to clinical candidates for Chk1, Hsp90, Bcl-2, Mcl-1, FAAH and A2A. We balance an internal portfolio of drug discovery projects with fully integrated research collaborations on targets with pharmaceutical companies and academic partners. Our shared-risk approach ensures a high level of engagement from our scientists and rewards success. Current disclosed collaborations include those with Servier, Daiichi Sankyo, Lundbeck and Asahi Kasei Pharma, and we seek additional partnerships.

How many employees does Vernalis have?

Vernalis has around 255 employees on LinkedIn.

Where is Vernalis headquartered?

Vernalis is headquartered in Cambridge, Cambs.

When was Vernalis founded?

Vernalis was founded in 1997.

Build a lead list from companies like Vernalis

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.